We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2002 by Control Delivery Systems.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00032396
First Posted: March 22, 2002
Last Update Posted: May 29, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bausch & Lomb Incorporated
Information provided by:
Control Delivery Systems
  Purpose
A study evaluating Retisert in patients with age-related macular degeneration

Condition Intervention Phase
Macular Degeneration Drug: Retisert Implant Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Control Delivery Systems:

Study Start Date: November 2001
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00032396


Locations
United States, Massachusetts
Control Delivery Systems, Inc.
Watertown, Massachusetts, United States, 02472
Sponsors and Collaborators
Control Delivery Systems
Bausch & Lomb Incorporated
  More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00032396     History of Changes
Other Study ID Numbers: CDS FL-004
First Submitted: March 20, 2002
First Posted: March 22, 2002
Last Update Posted: May 29, 2006
Last Verified: December 2002

Keywords provided by Control Delivery Systems:
AMD
ARMD
Age-Related Macular Degeneration
Subfoveal Choroidal Neovascularization
CNV

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Fluocinolone Acetonide
Anti-Inflammatory Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs